Literature DB >> 3598994

Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis.

T Pincus, L F Callahan, W K Vaughn.   

Abstract

Mortality over 9 years in rheumatoid arthritis was studied according to baseline demographic, disease, therapy and comorbidity variables, and measures of functional capacity variables. Significant differences between patients who survived and died over the next 9 years were seen for 8 variables: age, joint count, oral corticosteroid use, presence of concurrent heart disease, formal educational level, and 3 quantitative measures of functional capacity, questionnaire responses regarding activities of daily living, modified walking time and the button test. Five-year survivals of 50% or less were seen in patients with severely dysfunctional values for the 3 quantitative measures of functional capacity. Increased relative risk of mortality according to functional capacity measures was not explained by age, sex, duration of disease, smoking history, joint count, hand radiograph score, grip strength, morning stiffness, formal educational level, oral corticosteroid or parenteral gold use, or various comorbidities, and was not expected by a majority of physicians.

Entities:  

Mesh:

Year:  1987        PMID: 3598994

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  18 in total

1.  Sleep duration and reported functional capacity among black and white US adults.

Authors:  Perry Brimah; Franscene Oulds; Oladipupo Olafiranye; Mirnova Ceide; Shavon Dillon; Olasumbo Awoniyi; Joao Nunes; Girardin Jean-Louis
Journal:  J Clin Sleep Med       Date:  2013-06-15       Impact factor: 4.062

2.  Questionnaire to evaluate the effects of assistive devices and altered working methods in women with rheumatoid arthritis.

Authors:  U Nordenskiöld; G Grimby; S Dahlin-Ivanoff
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  A contrasting view on rheumatoid arthritis.

Authors:  L F Callahan; T Pincus; F Wolfe
Journal:  Am J Public Health       Date:  1989-09       Impact factor: 9.308

4.  Effect of social deprivation on disease severity and outcome in patients with rheumatoid arthritis.

Authors:  A McEntegart; E Morrison; H A Capell; M R Duncan; D Porter; R Madhok; E A Thomson
Journal:  Ann Rheum Dis       Date:  1997-07       Impact factor: 19.103

Review 5.  What happens to patients with rheumatoid arthritis? The long-term outcome of treatment.

Authors:  T D Spector; D L Scott
Journal:  Clin Rheumatol       Date:  1988-09       Impact factor: 2.980

Review 6.  The underestimated long term medical and economic consequences of rheumatoid arthritis.

Authors:  T Pincus
Journal:  Drugs       Date:  1995       Impact factor: 9.546

7.  Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis.

Authors:  A Häkkinen; H Kautiainen; P Hannonen; J Ylinen; M Arkela-Kautiainen; T Sokka
Journal:  Ann Rheum Dis       Date:  2004-05-06       Impact factor: 19.103

8.  Echocardiographic findings, 24-hour electrocardiographic Holter monitoring in patients with rheumatoid arthritis according to Steinbrocker's criteria, functional index, value of Waaler-Rose titre and duration of disease.

Authors:  M Wisłowska; S Sypuła; I Kowalik
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 9.  Challenges comparing functional limitations in rheumatoid arthritis and ankylosing spondylitis.

Authors:  G H Louie; J D Reveille; M M Ward
Journal:  Clin Exp Rheumatol       Date:  2009 Jul-Aug       Impact factor: 4.473

10.  Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.

Authors:  John H Kempen; Ebenezer Daniel; James P Dunn; C Stephen Foster; Sapna Gangaputra; Asaf Hanish; Kathy J Helzlsouer; Douglas A Jabs; R Oktay Kaçmaz; Grace A Levy-Clarke; Teresa L Liesegang; Craig W Newcomb; Robert B Nussenblatt; Siddharth S Pujari; James T Rosenbaum; Eric B Suhler; Jennifer E Thorne
Journal:  BMJ       Date:  2009-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.